Precision Medicine

Precision Medicine

 

The Medical Oncology Program includes enhanced reimbursement for treatment planning and care coordination services provided by network providers for those eligible members who enroll in NCI-Molecular Analysis for Therapy Choice (NCI-MATCH), a National Cancer Institute clinical trial.  NCI-MATCH seeks to determine whether treating cancers according to their molecular abnormalities will show evidence of effectiveness.

The Medical Oncology Program Precision Medicine component provides a unique opportunity to support the White House’s Precision Medicine Initiative through the National Cancer Institute to accelerate knowledge and learn as rapidly as possible which genes and therapies are clinically effective.  It also supports your practice with enhanced reimbursement for treatment planning and care coordination services provided to those eligible members who enroll in NCI-MATCH.